1. LCZ696, a combination of valsartan with a neprilysin inhibitor, significantly reduced the risk of death from cardiovascular causes and...

1. The EINSTEIN CHOICE trial involved patients who had a history of venous thromboembolism (VTE) and had completed 6 to...

1. The self-administered, subcutaneous C1-inhibitor CSL830 demonstrated a dose-dependent high efficacy in the prophylactic treatment of hereditary angioedema (HAE) attacks...

1. Patients with recurrent urothelial carcinoma experienced significantly longer median survival times when treated with pembrolizumab compared with chemotherapy agents.  ...

1. In pregnant women, treating subclinical hypothyroidism or hypothyroxinemia with levothyroxine did not significantly impact cognitive outcomes in children up to age...

1. The efficacy of imatinib in chronic phase chronic myeloid leukemia (CML) persisted after 10-year follow-up. 2. No new significant...

1. The study demonstrated that in critically ill pediatric patients, there was no significant difference in total number of ICU-free...

1. This prospective cohort study of patients with cardiac pacemakers or implantable cardioverter-defibrillators (ICDs) undergoing magnetic resonance imaging (MRI) demonstrated no...

1. Periviable infants born from 2008-2011 survived to 18-22 months corrected age at a higher rate than those born from...

1. Bariatric surgery significantly reduced and sustained glycated hemoglobin (HbA1c) levels compared to medical therapy at five-year follow-up. 2. Both...